“Visfatin Promotes Renal Cell Carcinoma Progression: Evidence from Clinical Samples and Cell Line Models”. Journal of Kidney Cancer, vol. 12, no. 3, Sept. 2025, pp. 58-65, https://doi.org/10.15586/jkcvhl.v12i3.427.